BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37041376)

  • 1. Plasma Stability and Plasma Metabolite Concentration-Time Profiles of Oligo(Lactic Acid)
    Repp L; Skoczen SL; Rasoulianboroujeni M; Stern ST; Kwon GS
    AAPS J; 2023 Apr; 25(3):39. PubMed ID: 37041376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
    Tam YT; Shin DH; Chen KE; Kwon GS
    J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligo(Lactic Acid)
    Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
    Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
    Tam YT; Gao J; Kwon GS
    J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl and oligo(lactic acid) prodrugs for PEG-b-PLA and PEG-b-PCL nano-assemblies for injection.
    Repp L; Rasoulianboroujeni M; Lee HJ; Kwon GS
    J Control Release; 2021 Feb; 330():1004-1015. PubMed ID: 33166607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereocomplex Prodrugs of Oligo(lactic acid)
    Tam YT; Huang C; Poellmann M; Kwon GS
    ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.
    Sun J; Chen Y; Li K; Huang Y; Fu X; Zhang X; Zhao W; Wei Y; Xu L; Zhang P; Venkataramanan R; Li S
    Acta Biomater; 2016 Oct; 43():282-291. PubMed ID: 27422196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.
    Shin HC; Cho H; Lai TC; Kozak KR; Kolesar JM; Kwon GS
    J Control Release; 2012 Oct; 163(1):93-9. PubMed ID: 22549011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.
    Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y
    Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced effect of folated pluronic F87-PLA/TPGS mixed micelles on targeted delivery of paclitaxel.
    Xiong XY; Pan X; Tao L; Cheng F; Li ZL; Gong YC; Li YP
    Int J Biol Macromol; 2017 Oct; 103():1011-1018. PubMed ID: 28552723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
    Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
    Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
    Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
    J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel.
    Yang R; Meng F; Ma S; Huang F; Liu H; Zhong Z
    Biomacromolecules; 2011 Aug; 12(8):3047-55. PubMed ID: 21726090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine-based paclitaxel induced apoptotic signaling pathways in A562 leukemia cancer cells.
    Wang Y; Zhou L; Xiao M; Sun ZL; Zhang CY
    Colloids Surf B Biointerfaces; 2017 Jan; 149():16-22. PubMed ID: 27716527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligo(Lactic Acid)
    Repp L; Unterberger CJ; Ye Z; Feltenberger JB; Swanson SM; Marker PC; Kwon GS
    Nanomaterials (Basel); 2021 Oct; 11(10):. PubMed ID: 34685195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel.
    Emami J; Rezazadeh M; Hasanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Rostami M; Davies N
    Int J Biol Macromol; 2015 Sep; 80():29-40. PubMed ID: 26093319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.
    Zhang L; He Y; Ma G; Song C; Sun H
    Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.